PRKN and neoplasm: In fact, several independent studies have highlighted the ability of PRKN to inhibit multiple intrinsic tumor traits of metabolic reprogramming (30, 66, 67), mitotic transitions (32), and cell motility and invasion (34), all independent of mitophagy.